VIA
AMPE

Vantage Investment Advisors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Vantage Investment Advisors’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-42
Closed -$94K – 804
2015
Q1 		$94K Buy
42
+21
+100% +$35.8K 0.03% 242
2014
Q4 		$21K Hold
21
– – 0.01% 371
2014
Q3 		$22K Buy
21
+3
+17% +$5.05K 0.01% 342
2014
Q2 		$45K Buy
18
+8
+80% +$16.3K 0.03% 249
2014
Q1 		$19K Buy
+10
New +$23.6K 0.01% 357

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Vantage Investment Advisors's AMPE Position: Q2 2015 in Review

Vantage Investment Advisors sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2015, closing a stake of 42 shares — an estimated $94K sold.

Vantage Investment Advisors first reported a position in AMPE in Q1 2014 and held it in 5 quarters. The position peaked at $94K in Q1 2015. 64 funds tracked by Wall St. Rank hold AMPE as of Q2 2015.

  • Vantage Investment Advisors reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2015 after selling out during the quarter.
  • Vantage Investment Advisors sold 42 Ampio Pharmaceuticals Inc. shares in Q2 2015, an estimated $94K.
  • Vantage Investment Advisors first reported a position in Ampio Pharmaceuticals Inc. in Q1 2014 and held it in 5 quarters.
  • Vantage Investment Advisors's Ampio Pharmaceuticals Inc. position peaked at $94K in Q1 2015.
  • 64 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2015.

Based on Vantage Investment Advisors's 13F filing for Q2 2015, filed 5 Aug 2015.